Featured Insights
-
Essential Guide To Cell And Gene Therapy Commercialization
10/10/2023
After devoting time, expertise, and financial resources to developing a transformative cell or gene therapy, it is essential to ensure patients can receive all of the benefits of your innovation.
-
Strategic Management Of The Mature Product Portfolio
4/7/2024
Explore a new outsourcing paradigm that integrates expertise, regulatory knowledge, efficiency, and cost containment, moving beyond traditional low-cost offshore staffing models.
-
Improving Access And Support For Cell And Gene Therapies
10/9/2023
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.
-
The Evolution Of The Cell And Gene Therapy Field
9/29/2023
Lung-I Cheng, Vice President, Cell and Gene Therapy, AmerisourceBergen, discusses emerging trends in the CGT market and details the value of leveraging the expertise of knowledgeable partners and stakeholders.